|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization of intangible assets | |||||
| Amortization of deferred costs | |||||
| Amortization of ROU asset, lease modification, impairment, and abandonment | |||||
| Stock based compensation | |||||
| Accretion of discount rate on lease liabilities | |||||
| Provision for doubtful accounts | |||||
| Deferred income taxes | |||||
| Losses from disposition of assets | |||||
| Losses and impairment on investments | |||||
| Impairment of finite-lived intangible assets | |||||
| Impairment of intangibles and other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Unbilled revenue, net | |||||
| Prepaid expenses, net | |||||
| Other payroll assets | |||||
| Other assets | |||||
| Other liabilities | |||||
| Accounts payable and other liabilities | |||||
| Client deposits and other client liabilities | |||||
| Accrued wages | |||||
| Accrued health insurance costs, net | |||||
| Accrued workers' compensation costs, net | |||||
| Payroll taxes payable and other payroll withholdings | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale and maturity of marketable securities | |||||
| Acquisitions of property and equipment and software | |||||
| Acquisitions of subsidiaries, net of cash acquired | |||||
| Proceeds from sale of business | |||||
| Other Investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Change in WSE and TriNet Trust related assets and liabilities, net | |||||
| Repurchase of common stock | |||||
| Proceeds from issuance of common stock | |||||
| Payment of long-term financing costs and debt issuance costs | |||||
| Proceeds from issuance of 2031 Notes | |||||
| 2031 Notes Payable | |||||
| 2029 Notes Payable | |||||
| Total proceeds from issuance of 2031 Notes | |||||
| Repayment of borrowings | |||||
| Proceeds from revolving credit agreement borrowings | |||||
| Repayment of revolving credit agreement borrowings | |||||
| Awards effectively repurchased for required employee withholding taxes | |||||
| Dividends paid | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents, unrestricted and restricted | |||||
| Cash and cash equivalents, unrestricted and restricted: | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Supplemental schedule of noncash investing and financing activities | |||||
| Cash dividend declared, but not yet paid | |||||
| Payable for purchase of property and equipment | |||||
| Acquisitions of subsidiaries paid in stock | |||||
| Receivable from sale of business | |||||
Loading...